%0 Journal Article
%A Aslan, Özgür
%T How should one read “real-life data” regarding NOAC’s? “The case with rivaroxaban”
%D 2017
%J Turk Kardiyol Dern Ars
%P 26-32
%V 45
%N 0
%R 10.5543/tkda.2017.33903
%M 28947728
%U https://dx.doi.org/10.5543/tkda.2017.33903